Philippines vs Saudi Arabia: Percentage of bloodstream infection due to methicillin-resistant
Philippines
44.4%
in 2022
Saudi Arabia
52.0%
in 2022
Philippines rank
15th
Saudi Arabia rank
12th
Percentage of bloodstream infection due to methicillin-resistant over time
- Philippines
- Saudi Arabia
How they compare
Saudi Arabia currently reports 52.0% against 44.4% in Philippines, a difference of 7.6%.
That makes Saudi Arabia's figure about 1.2 times Philippines's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Philippines ahead.
Philippines ranks 15th and Saudi Arabia ranks 12th of 50 countries.
Across the 2 decades both report, Philippines averaged higher in 1 and Saudi Arabia in 1.
Head to head by decade
| Decade | Philippines | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 54.8% | 42.8% | 11.9% | Philippines |
| 2020s | 44.9% | 67.5% | 22.6% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Philippines or Saudi Arabia?
- Saudi Arabia, at 52.0% against 44.4% in Philippines as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Philippines and Saudi Arabia?
- 7.6%, with Saudi Arabia ahead.
- How many years of comparable data are there for Philippines and Saudi Arabia?
- 6 years are reported by both, from 2017 to 2022.
- How do Philippines and Saudi Arabia rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Philippines ranks 15th and Saudi Arabia ranks 12th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.